Home ›
Organizations ›
ODYLIA THERAPEUTICS INC
ODYLIA THERAPEUTICS INC
GA · Medical Research · EIN 822120760
3
Executives Disclosed
$482K
Annual Revenue
$1.6M
Total Assets
ODYLIA THERAPEUTICS INC has 3 executives with disclosed compensation. The highest-paid executive, Ashley Winslow (CEO/CSO), received peak total compensation of $230,695. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Ashley Winslow | CEO/CSO | $231K | $225K | 2019–2024 | 3.1x |
| Jennifer Klein | MGR. OF OPERATIONS & PROG. MGMT. | $116K | $0 | 2024–2024 | 1.6x |
| Jenny Klein | MANAGER OF OPERATIONS & PROGRAM MANAGEMENT | $109K | $0 | 2023–2023 | 1.5x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2019 | 1 | $0 | $0 | $0 |
| 2020 | 1 | $199K | $199K | $199K |
| 2021 | 1 | $214K | $214K | $214K |
| 2022 | 1 | $211K | $211K | $211K |
| 2023 | 2 | $231K | $231K | $231K |
| 2024 | 2 | $225K | $225K | $225K |
Email Alerts
Get notified about ODYLIA THERAPEUTICS INC
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.